BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes

Molecular and Cellular Biology

Volumn 33, Issue 19, 2013, Pages 3849-3863

  Sena, Johnny A ^a   Wang, Liyi ^a   Hu, Cheng Jun ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRG1 PROTEIN; BRM PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANGIOPOIETINS; ANIMALS; ANTIGENS, NEOPLASM; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARBONIC ANHYDRASES; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; ERYTHROPOIETIN; GENE EXPRESSION; HEK293 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NUCLEAR PROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 84886791750     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00731-13     Document Type: Article

References (39)

1. Finger EC, Giaccia AJ. 2010. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 29:285-293.
2. Kaelin WG, Jr. 2011. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb. Symp. Quant. Biol. 76:335-345.
3. Keith B, Johnson RS, Simon MC. 2012. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12:9-22.
4. Semenza GL. 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148:399-408.
5. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. U. S. A. 97:9082-9087.
6. Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, Dicker DT, El-Deiry WS. 2005. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol. Ther. 4:1285-1294.
7. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. 2002. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. U. S. A. 99:12825-12830.
8. -/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27. Mol. Cell. Biol. 25:4565-4578.
9. Mazumdar J, Hickey MM, Pant DK, Durham AC, Sweet-Cordero A, Vachani A, Jacks T, Chodosh LA, Kissil JL, Simon MC, Keith B. 2010. HIF-2α deletion promotes Kras-driven lung tumor development. Proc. Natl. Acad. Sci. U. S. A. 107:14182-14187.
10. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:6669-6673.
11. Pawlus MR, Wang L, Hu CJ. 22 April 2013. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. [Epub ahead of print.] doi:10.1038/onc.2013.115.
12. Pawlus MR, Wang L, Ware K, Hu CJ. 2012. Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia. Mol. Cell. Biol. 32:4595-4610.
13. Ebert BL, Bunn HF. 1998. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell. Biol. 18:4089-4096.
14. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, Poellinger L. 1998. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17:6573-6586.
15. Ruas JL, Berchner-Pfannschmidt U, Malik S, Gradin K, Fandrey J, Roeder RG, Pereira T, Poellinger L. 2010. Complex regulation of the transactivation function of hypoxia-inducible factor-1α by direct interaction with two distinct domains of the CREB-binding protein/p300. J. Biol. Chem. 285:2601-2609.
16. Cairns BR. 2009. The logic of chromatin architecture and remodelling at promoters. Nature 461:193-198.
17. Hargreaves DC, Crabtree GR. 2011. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 21:396-420.
18. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W. 2000. A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol. Cell. Biol. 20:8879-8888.
19. Trotter KW, Archer TK. 2008. The BRG1 transcriptional coregulator. Nucl. Recept. Signal. 6:e004. doi:10.1621/nrs.06004.
20. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. 1993. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366:170-174.
21. Sif S, Saurin AJ, Imbalzano AN, Kingston RE. 2001. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15:603-618.
22. Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, Simon MC. 2006. Differential regulation of the transcriptional activities of hypoxiainducible factor 1α (HIF-1α) and HIF-2α in stem cells. Mol. Cell. Biol. 26:3514-3526.
23. Hu CJ, Sataur A, Wang L, Chen H, Simon MC. 2007. The N-terminal transactivation domain confers target gene specificity of hypoxiainducible factors HIF-1α and HIF-2α. Mol. Biol. Cell 18:4528-4542.
24. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. 2003. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23:9361-9374.
25. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, Eckardt KU. 2004. Differentiating the functional role of hypoxiainducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J. 18:1462-1464.
26. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavtigian SV, Teng DH, Lees E. 2000. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res. 60:6171-6177.
27. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, Carey M, Smale ST. 2009. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128.
28. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, Smale ST. 2006. Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20:282-296.
29. Grabmaier K, de Weijert MCA, Verhaegh GW, Schalken JA, Oosterwijk E. 2004. Strict regulation of CAIX(G250/MN) by HIF-1α in clear cell renal cell carcinoma. Oncogene 23:5624-5631.
30. Reisman D, Glaros S, Thompson EA. 2009. The SWI/SNF complex and cancer. Oncogene 28:1653-1668.
31. Roberts CW, Orkin SH. 2004. The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer 4:133-142.
32. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. 2005. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindauassociated renal cell carcinoma. Mol. Cell. Biol. 25:5675-5686.
33. Kenneth NS, Mudie S, van Uden P, Rocha S. 2009. SWI/SNF regulates the cellular response to hypoxia. J. Biol. Chem. 284:4123-4131.
34. Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, Hankinson O. 2004. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 279:46733-46741.
35. Wang F, Zhang R, Wu X, Hankinson O. 2010. Roles of coactivators in hypoxic induction of the erythropoietin gene. PLoS One 5:e10002. doi:10 .1371/journal.pone.0010002.
36. Brownlee PM, Chambers AL, Oliver AW, Downs JA. 2012. Cancer and the bromodomains of BAF180. Biochem. Soc. Trans. 40:364-369.
37. Wu JN, Roberts CW. 2013. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov. 3:35-43.
38. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E. 1999. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWISNF complex, and alters the ability of BRG1 to induce growth arrest. Mol. Cell. Biol. 19:1460-1469.
39. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. 2007. HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11:335-347.